| Biotechnology Industry | Healthcare Sector | Mr. Akshay Bansarilal Arora CEO | MSE Exchange | INE0KBH01020 ISIN |
| IN Country | 196 Employees | 11 Sep 2026 Last Dividend | - Last Split | - IPO Date |
Blue Jet Healthcare Limited specializes in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), which are essential for pharmaceutical and healthcare products. With a history that dates back to 1968, the company has established itself as a key player in the healthcare sector. Blue Jet Healthcare Limited boasts a global presence, conducting operations in various countries including India, Norway, the United States, Sweden, Italy, Spain, and other international markets. Headquartered in Thane, India, the company is committed to delivering high-quality products and development services to its clients worldwide.
Blue Jet Healthcare Limited provides a range of integrated contrast media intermediates used in medical imaging. These intermediates are critical for diagnostic procedures that require contrasting agents to improve the clarity of the images.
The company manufactures saccharin and its related salts, which are widely used as artificial sweeteners in various food and pharmaceutical products. This offering is part of their niche portfolio, catering to specific industry needs.
In addition to saccharin and contrast media intermediates, Blue Jet Healthcare Limited produces niche pharmaceutical intermediates and APIs. These components are essential for the creation of a wide range of pharmaceutical and healthcare products, underlining the company's versatility in the pharma sector.
Expanding its capability beyond manufacturing, Blue Jet Healthcare Limited offers Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) services. These services are designed to support pharmaceutical companies throughout the development, scaling, and manufacturing process, ensuring high-quality end products.